Class A and D Extended-Spectrum β-Lactamases in Imipenem Resistant Pseudomonas aeruginosa Isolated From Burn Patients

Sanaz Pakbaten Toupkanlou1, Shahin Najar Peerayeh1, Rahim Pirhajati Mahabadi1

  • 1Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran.

Abstract

Insights

Multidrug-resistant Pseudomonas aeruginosa, a major cause of burn wound infections, frequently exhibits resistance genes like bla PER, bla OXA-10, bla TEM, and bla SHV in Iran. This poses a significant threat to burn care.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa is a critical pathogen in burn wound infections, leading to significant mortality.
  • Antibiotic resistance in P. aeruginosa complicates treatment and increases patient risk.

Purpose of the Study:

  • To determine the prevalence of Ambler class A and D beta-lactamases in P. aeruginosa from burn infections in Tehran, Iran.
  • To investigate the genetic basis of resistance in these isolates.

Main Methods:

  • Bacteriological samples were collected from burn patients with clinical signs of infection.
  • Fifty P. aeruginosa isolates were identified based on phenotypic characteristics and confirmed by PCR.
  • Antibiotic susceptibility testing and phenotypic screening for beta-lactamases were performed, followed by PCR for specific resistance genes (bla PER, bla OXA-10, bla TEM, bla SHV, bla KPC, bla GES).

Main Results:

  • 88% of P. aeruginosa isolates were multidrug-resistant.
  • Prevalence of specific beta-lactamase genes: bla PER (14%), bla OXA-10 (36%), bla TEM (36%), and bla SHV (36%).
  • No isolates carried bla KPC or bla GES genes.

Conclusions:

  • High levels of multidrug resistance and the presence of PER, OXA-10, SHV, and TEM beta-lactamases are prevalent in imipenem-resistant P. aeruginosa from Iranian burn patients.
  • This resistance pattern represents a substantial threat to burn centers in Iran.
  • Urgent strategies are needed to combat the spread of antibiotic resistance in P. aeruginosa.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
34
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
102
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
69
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
38